Virtual Cycling for Parkinson's Disease

(VCYCLE_PD Trial)

Overseen By Sharon McFarlane

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Rutgers, The State University of New Jersey

Disqualifiers: Severe heart disease, severe lung disease, uncontrolled diabetes, traumatic brain injury, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 3

60 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This study asks three questions about Persons with Parkinson Disease that use a bicycle for exercise. 1. Does the use of virtual reality increase the intensity and and enjoyment of the experience compared to bicycling without virtual reality? 2. Does the way in which the bicycling (interval compared to continous) is performed affect the experience? 3. How does the way the virtual reality is delivered (with goggles or projected on a screen) affect the experience?

Who Is on the Research Team?

Judith E. Deutsch, PT PhD

Principal Investigator

Rutgers

Are You a Good Fit for This Trial?

This trial is for people aged 45-75 with Parkinson's Disease at stages II-III who can ride a stationary bike and sign consent. Excluded are those with vision/hearing issues, severe heart/lung disease, uncontrolled diabetes, recent brain injury or surgery, moderate depression, or any condition preventing safe cycling.

Inclusion Criteria

My Parkinson's disease is at a moderate stage.

I can ride a stationary bike.

I am between 45 and 75 years old.

Exclusion Criteria

I have been diagnosed with moderate depression.

I don't have any health issues that would stop me from riding a bicycle.

I have a health issue that stops me from riding a bike.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 day

1 visit (in-person)

Session 1

Participants complete movement assessments and questionnaires, and bicycle in semi-immersive and immersive virtual environments

1 day

1 visit (in-person)

Session 2

Participants bicycle four times with and without a virtual environment using both continuous and interval modes, with oxygen consumption measured

1 day

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the sessions

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Virtual Cycling Environments

Trial Overview The study tests if virtual reality enhances the biking experience for Parkinson's patients in terms of enjoyment and exercise intensity. It compares continuous to interval biking and examines different VR delivery methods (goggles vs screen projection).

How Is the Trial Designed?

Group I: Virtual Reality Experimental Treatment 1 Intervention

This is a single arm study in which all participants will execute the same tasks over two sessions.

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials

471

Recruited

81,700+

New York Institute of Technology

Collaborator

Trials

56

Recruited

2,300+

National Institute on Aging (NIA)

Collaborator

Trials

1,841

Recruited

28,150,000+